Correlation Between PDS Biotechnology and Icosavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Icosavax, you can compare the effects of market volatilities on PDS Biotechnology and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Icosavax.

Diversification Opportunities for PDS Biotechnology and Icosavax

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between PDS and Icosavax is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Icosavax go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Icosavax

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Icosavax. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 1.22 times less risky than Icosavax. The stock trades about -0.04 of its potential returns per unit of risk. The Icosavax is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  850.00  in Icosavax on August 31, 2024 and sell it today you would earn a total of  52.00  from holding Icosavax or generate 6.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy28.45%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Icosavax

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Icosavax 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Icosavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Icosavax is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

PDS Biotechnology and Icosavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Icosavax

The main advantage of trading using opposite PDS Biotechnology and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.
The idea behind PDS Biotechnology Corp and Icosavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Directory
Find actively traded commodities issued by global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data